Jul 29, 2019 04:15PM
Jul 22, 2019 02:00PM
Jun 27, 2019 08:05AM
Jun 27, 2019 08:00AM
Jun 20, 2019 04:31PM
Jun 20, 2019 04:30PM
Jun 18, 2019 08:48AM ContraVir Pharma (CTRV) Prices Public Offering with Expected Total Gross Proceeds of Approx. $15.6M
Jun 18, 2019 08:45AM
Jun 17, 2019 08:09AM
Jun 17, 2019 08:00AM
Jun 11, 2019 08:32AM
Jun 11, 2019 08:30AM
Jun 6, 2019 08:00AM
May 31, 2019 08:02AM ContraVir Pharma (CTRV) Announces 1-for-70 Reverse Stock Split
May 31, 2019 08:00AM
May 6, 2019 08:12AM
May 6, 2019 08:00AM
Apr 29, 2019 08:30AM
Apr 25, 2019 09:05AM
Apr 25, 2019 09:02AM
Apr 11, 2019 08:07AM ContraVir Pharma (CTRV) to Present CRV431 Phase 1 Data at EASL
Apr 11, 2019 08:00AM
Mar 4, 2019 02:01PM
Jan 15, 2019 06:25PM
Jan 3, 2019 08:45AM
Jan 3, 2019 08:45AM
Nov 27, 2018 04:30PM
Nov 6, 2018 08:00AM ContraVir Pharmaceuticals to Present Two Posters at The Liver Meeting® 2018, Hosted by the American Association for the Study of Liver Diseases
Oct 30, 2018 08:26AM
Oct 30, 2018 08:05AM
Oct 30, 2018 08:00AM
Oct 3, 2018 08:00AM
Sep 18, 2018 09:00AM
Aug 7, 2018 09:03AM
Aug 7, 2018 09:00AM ContraVir Pharmaceuticals Completes Data Analysis of Second Cohort in Part 1 of the Phase 1/2a Study of CRV431
Aug 6, 2018 03:34PM
Aug 6, 2018 03:30PM
Jul 23, 2018 08:04AM
Jul 23, 2018 08:00AM
Jun 29, 2018 08:00AM
Jun 25, 2018 08:00AM
Jun 21, 2018 08:00AM ContraVir Pharmaceuticals Announces Data on Optimized Formulation of TXL™
Jun 14, 2018 08:23AM
Jun 14, 2018 08:13AM
Jun 14, 2018 08:00AM
Jun 12, 2018 12:17PM
Jun 5, 2018 09:00AM
May 31, 2018 08:00AM
May 30, 2018 08:05AM ContraVir Pharma (CTRV) Says its Inhibitor, CRV431, Reduces Development and Progression of Liver Tumors in Preclinical Hepatocellular Carcinoma Study
May 30, 2018 08:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All